Amiel Balagtas

Amiel Balagtas has a diverse work experience spanning over several decades. Amiel most recently served as the Vice President of Development Operations at Corcept Therapeutics starting in March 2022. Prior to that, they held various executive roles at Gilead Sciences from 1998 to 2022, including Executive Director of Development Systems and Executive Director of Medical Communications & Operations. Before joining Gilead Sciences, Amiel worked in the healthcare and research fields, with positions at the University of California, San Francisco; Stanford School of Medicine; and the University of California, Los Angeles. Amiel'searly career also involved clinical research at the John Wayne Cancer Institute.

Amiel Balagtas holds a Bachelor of Science degree from UCLA. However, the start and end years for this degree are not specified. Following this, from 2012 to 2015, Amiel pursued further education at Golden Gate University, Edward S. Ageno School of Business, where they obtained a Masters in Business Administration degree. The field of study for both degrees is not provided.